SCR-LIP-000040 · Claim · machine-readable JSON →

There is no scientific evidence supporting gestrinone for lipedema: a PRISMA systematic review identified zero clinical trials, observational studies or case reports evaluating it, particularly as subcutaneous implants.

Evidence gap therapeutic Evidence certainty: moderate (GRADE)

Evidence over time

20252025 · contradicting · DOI:10.7759/cureus.97213

Evidence (1)

Context (PECO)

Populationpatients with lipedema
Conditionlipedema
Exposuregestrinone (off-label, incl. subcutaneous implants)
Comparatorevidence-based conservative care
Outcomeno eligible evidence of efficacy/safety
Scopesystematic review to July 2025

Answers these questions

Gaps & caveats

Absence of evidence (no studies) rather than demonstrated lack of effect; implant pharmacokinetics/safety never studied.